Net Cash Provided by (Used in) Financing Activities in USD of GUIDED THERAPEUTICS INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GUIDED THERAPEUTICS INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • GUIDED THERAPEUTICS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $58K.
  • GUIDED THERAPEUTICS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $916K, a 3717% increase from 2023.
  • GUIDED THERAPEUTICS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $24K, a 99.2% decline from 2022.
  • GUIDED THERAPEUTICS INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.18M, a 53.8% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $58K +$104K 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 -$46K -$69K -300% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 $23K -$252K -91.6% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $275K -$1.11M -80.2% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $1.39M +$1.73M 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 -$348K -$540K -281% 01 Jan 2020 31 Mar 2020 10-Q/A 18 Aug 2021
Q1 2019 $192K -$278K -59.1% 01 Jan 2019 31 Mar 2019 10-Q 07 Jul 2020
Q1 2018 $470K +$76K +19.3% 01 Jan 2018 31 Mar 2018 10-Q 11 Jul 2019
Q1 2017 $394K -$582K -59.6% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q1 2016 $976K +$494K +102% 01 Jan 2016 31 Mar 2016 10-Q 22 May 2017
Q1 2015 $482K +$82K +20.5% 01 Jan 2015 31 Mar 2015 10-Q 19 May 2016
Q1 2014 $400K -$1.08M -73% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q1 2013 $1.48M +$1.36M +1093% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q1 2012 $124K -$3K -2.36% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q1 2011 $127K 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012

GUIDED THERAPEUTICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $916K +$892K +3717% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $24K -$3.16M -99.2% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $3.18M +$1.11M +53.8% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $2.07M +$908K +78.3% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $1.16M -$546K -32% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $1.71M +$341K +25% 01 Jan 2019 31 Dec 2019 10-K 07 Apr 2021
2018 $1.36M +$233K +20.6% 01 Jan 2018 31 Dec 2018 10-K 20 Apr 2020
2017 $1.13M -$650K -36.5% 01 Jan 2017 31 Dec 2017 10-K 08 May 2019
2016 $1.78M -$2.14M -54.6% 01 Jan 2016 31 Dec 2016 10-K/A 20 Apr 2018
2015 $3.92M -$2.06M -34.4% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017
2014 $5.98M +$751K +14.4% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016
2013 $5.23M +$2.17M +70.8% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2015
2012 $3.06M +$693K +29.2% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014
2011 $2.37M -$1.2M -33.7% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013
2010 $3.57M 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.